Profile
Sector:
HealthcareIndustry:
Medical Instruments & SuppliesCountry:
United StatesIPO:
05 August 2005Website:
http://www.atricure.comNext earnings report:
14 February 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 20 Nov 2024 21:02:30 GMTDividend
Analysts recommendations
Institutional Ownership
ATRC Latest News
AtriCure, Inc. (NASDAQ:ATRC ) Q3 2024 Earnings Conference Call October 29, 2024 4:30 PM ET Company Participants Marissa Bych - Investor Relations Michael Carrel - President and Chief Executive Officer Angela Wirick - Chief Financial Officer Conference Call Participants Lilia Lozada - JPMorgan Mike Matson - Needham Danielle Antalffy - UBS Suraj Kalia - Oppenheimer & Co. Operator Good afternoon. And welcome to AtriCure's Third Quarter 2024 Earnings Conference Call.
While the top- and bottom-line numbers for AtriCure (ATRC) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
AtriCure (ATRC) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.20 per share a year ago.
ATRC's cryoSPHERE MAX probe cuts freeze times by 50%, advancing Cryo Nerve Block therapy to improve post-op pain relief and reduce opioid dependency risks.
ATRC's EnCompass Clamp receives a CE Mark, enabling European surgeons to access faster, simpler heart ablation in cardiac surgeries with advanced radiofrequency technology.
ATRC announces the treatment of the first patient using the AtriClip FLEX-Mini device.
AtriCure (ATRC) announces the receipt of an expanded CE-Mark indication for its AtriClip devices for reducing strokes in patients with Afib.
AtriCure, Inc. (NASDAQ:ATRC ) Q2 2024 Earnings Conference Call July 30, 2024 4:30 PM ET Company Participants Marissa Bych - Investor Relations Michael Carrel - President and Chief Executive Officer Angela Wirick - Chief Financial Officer Conference Call Participants Lilia Lozada - JPMorgan John Newman - Canaccord Genuity John McAulay - Stifel Financial Corp. Sam Eiber - BTIG Danielle Antalffy - UBS Daniel Stauder - Citizens JMP Suraj Kalia - Oppenheimer & Co. Joseph Conway - Needham & Company Operator Good afternoon, And welcome to AtriCure's Second Quarter 2024 Earnings Conference Call. This call is being recorded for replay purposes.
The headline numbers for AtriCure (ATRC) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
AtriCure (ATRC) receives NMPA approval to market AtriClip Left Atrial Appendage Exclusion System in China, marking a significant step in global expansion.
- 1(current)
What type of business is AtriCure?
AtriCure, Inc. is a large healthcare system company that specializes in the development, manufacturing, and sale of equipment and systems for physicians working in the field of cardiothoracic surgery in the United States and abroad. The company was founded in 2000 and is based in Mason, Ohio. The company's portfolio includes 3 categories of products: Products for open and minimally invasive ablation include a range of Synergy Isolator clamps for the treatment of persistent atrial fibrillation. The company's products for open ablation include the CryoICE cryoablation system. Products for minimally invasive ablation provide a coagulation system under EPi-Sense control with VisiTrax technology, using monopolar energy for tissue coagulation.
What sector is AtriCure in?
AtriCure is in the Healthcare sector
What industry is AtriCure in?
AtriCure is in the Medical Instruments & Supplies industry
What country is AtriCure from?
AtriCure is headquartered in United States
When did AtriCure go public?
AtriCure initial public offering (IPO) was on 05 August 2005
What is AtriCure website?
https://www.atricure.com
Is AtriCure in the S&P 500?
No, AtriCure is not included in the S&P 500 index
Is AtriCure in the NASDAQ 100?
No, AtriCure is not included in the NASDAQ 100 index
Is AtriCure in the Dow Jones?
No, AtriCure is not included in the Dow Jones index
When was AtriCure the previous earnings report?
No data
When does AtriCure earnings report?
The next expected earnings date for AtriCure is 14 February 2025